Emergent BioSolutions awarded BARDA contract for Ebola treatment www.cidrap.umn.edu/avian-influe...
The contract option will cover steps such as scale-up process validation and commercial readiness.
eingesetzter Impfstoffe verhindern, wie etwa des Pockenimpfstoffs ACAM2000 von Emergent BioSolutions. www.forbes.com/sites/robert...
The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of mpox lesions in infected animals compared to Bavarian Nordic’s licensed vacc...
🚨FDA approves Emergent BioSolutions’ ACAM2000 vaccine(live vaccinia virus) for MPOX, which has black box warnings for myopericarditis, encephalitis, and severe vaccinial infections that can result in severe disability and/or death. investors.emergentbiosolutions.com/news-release...
@AlArabiya_Eng: The US Food and Drug Administration (FDA) has approved expanded use of Emergent BioSolutions’ ACAM2000 smallpox vaccine to include people at high risk for #mpox infection, the company says.
Emergent BioSolutions akan Donasi 50 Ribu Dosis Vaksin Mpox ke Afrika
ACAM2000 merupakan vaksin virus hidup yang dapat bereplikasi
Emergent BioSolutions receives $50M f. Johnson & Johnson http://dlvr.it/T9TJpPhttp://dlvr.it/T9TJpZ
